Menu Close

Trending

Merck makes circular RNA play with $3.5bn Orna alliance
On heels of new data, Gilead pays $455m for Asian Trodelvy rights
Roche eyes April FDA verdict on Polivy as first-line lymphoma therapy
Digital health’s rapid growth spurt comes home to roost
FDA grants swift review to Lynparza in first-line prostate cancer

Wilmington Healthcare

Prescription2

Healthcare/ Pharma Market Access/ UK & Europe/ Views and analysis

The changing frontline: how to engage with England’s NHS in 2018

, , , , 0 Comment

Wilmington Healthcare-pharmaphorum conference: England’s NHS is moving towards integrated care, and long-term outcomes-based contracts for medicines could become the norm

X
The changing frontline: how to engage with England’s NHS in 2018
https://pharmaphorum.com/views-and-analysis/changing-frontline-engage-englands-nhs-2018/
Manchester, UK - 4 May 2017: Exterior Of Manchester Town Hall Building

Healthcare/ Pharma Market Access/ UK & Europe/ Views and analysis

Manchester setting the pace in NHS move to outcomes-based deals

, , , , 0 Comment

The NHS is moving rapidly towards integrated care models – and outcomes-based deals with pharma will also play a role.

X
Manchester setting the pace in NHS move to outcomes-based deals
https://pharmaphorum.com/views-and-analysis/manchester-setting-pace-nhs-move-outcomes-based-deals/

Login

CONTINUE TO SITE >
X
Close in 10 seconds